Concepedia

Mukesh Chhanabhai

MC

38

Publications

8.1K

Citations

33

H-Index

1997

Active since

Affiliations

BC Cancer Agency(Current)

University of British Columbia

Vancouver General Hospital

Dana-Farber Cancer Institute

University of Lübeck

Mukesh Chhanabhai is an author at BC Cancer Agency specializing in medicine, pathology, and immunology.

Top concepts

Publications per year

1997–2013

38

Publications

38

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai et al. · Blood · 2006 · 1.5K citations

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Laurie H. Sehn, Jane Donaldson, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2005 · 982 citations · Full text

ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Kerry J. Savage, Nancy L. Harris, Julie M. Vose et al. · Blood · 2008 · 845 citations · Full text

Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma

Randy D. Gascoyne, Patricia Aoun, Daniel Wu et al. · Blood · 1999 · 480 citations

Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma

Randy D. Gascoyne, Patricia Aoun, Daniel Wu et al. · Blood · 1999 · 432 citations

Rows per page

1–5 of 38